Overview

Prophylaxis for COVID-19: Ivermectin in Close Contacts of COVID-19 Cases (IVERNEX-TUC)

Status:
Recruiting
Trial end date:
2021-05-30
Target enrollment:
Participant gender:
Summary
Randomized controlled clinical trial on using oral ivermectin in COVID-19 prophylaxis supplying the drug to close contacts of confirmed cases.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Ministry of Public Health, Argentina
Treatments:
Ivermectin